Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Penicillium camemberti
- Development stage
- Unknown
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Intradermal, Topical
01
Overview
*Penicillium camemberti* is a domesticated filamentous fungus primarily known for its essential role in the ripening of soft cheeses such as Camembert and Brie. Beyond its culinary applications, it is investigated for its therapeutic and biotechnological potential. Clinical research has demonstrated that a milk-based culture of *P. camemberti* (MCW) can help maintain cognitive functions, particularly short-term and working memory, and improve sleep quality in elderly populations. These effects are hypothesized to be mediated by the fermentation-derived metabolite oleamide, which may modulate brain-derived neurotrophic factor (BDNF) levels. Additionally, the fungus produces various bioactive secondary metabolites, including penicamins (polyoxygenated diterpenes) with immunosuppressive properties and fumigermin, a compound with potential cosmetic applications for skin whitening and wrinkle reduction. It also serves as a source of industrial enzymes, such as lipases used in chemical synthesis and food quality control.
- Other names
- white moldCamembert mold
02
Targets
BDNF (Brain-derived neurotrophic factor)
Beyond the preview
Go deeper on Penicillium camemberti.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Penicillium camemberti.